Michael Zeunert

Michael Zeunert currently serves as the Director of Program Management for Life Science Product Development at QIAGEN, where he plays a pivotal role in steering the company's innovative instrument platform initiatives. In this capacity, Michael oversees a $20 million development program, leveraging his extensive expertise in project governance, cross-functional leadership, and stakeholder management to ensure the successful delivery of complex, high-impact projects. His strategic focus on optimizing the life science development portfolio has led to significant improvements in project execution efficiency, risk mitigation, and resource allocation, aligning with QIAGEN’s broader mission to advance molecular testing solutions.

Michael’s deep experience in IVD and RUO product redevelopment is instrumental in bridging R&D, Operations, and Marketing functions, fostering seamless collaboration across departments. His leadership in implementing a Corporate Project Management Office has standardized project management practices, enhanced process engineering, and strengthened project governance frameworks, resulting in more predictable project outcomes and accelerated time-to-market for critical life science products. Additionally, his contributions extend to driving process improvements within the development pipeline, integrating tools like MS Project, SAP, and advanced Excel analytics to monitor project performance and facilitate data-driven decision-making.

Beyond operational excellence, Michael actively contributes to QIAGEN’s strategic initiatives, including the company’s response to epidemic threats, by leading programs that enhance product development agility and innovation. His proven ability to negotiate, build stakeholder consensus, and lead multidisciplinary teams underscores his value as a senior leader committed to advancing life science research and diagnostics through robust project management and strategic execution.